NIB still waiting for pandemic-delayed surgeries, profit up

Ayesha de KretserSenior reporter

Feb 21, 2022 – 9.52am

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Already a subscriber?

NIB Holdings chief executive Mark Fitzgibbon says the omicron variant kept people from scheduling non-urgent surgeries throughout the six months to December 31 and even into January, after the health insurer delivered a 25 per cent increase in interim net profit to $81.4 million.

NIB increased its interim dividend by 10 per cent to 11¢ a share after premium revenue grew 8.2 per cent, with the pandemic spurring more people to take policies.

Ayesha de Kretser is a senior reporter with The Australian Financial Review covering the aviation and tourism sectors. She has previously reported on banking, mining and commodity markets.